Rafael Cardoso Maciel Costa Silva

Prof. Rafael Cardoso Maciel Costa Silva

Faculty of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro, Brazil
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2018 in Genes
Verified
Journal Article
Open access
PDF file
BPBruno R. B. Pires
Bruno R. B. Pires
Rafael Cardoso Maciel Costa SilvaRafael Cardoso Maciel Costa Silva
Rafael Cardoso Maciel Costa Silva
GFGerson Moura Ferreira
Gerson Moura Ferreira
EAEliana Saul Furquim Werneck Abdelhay
Eliana Saul Furquim Werneck Abdelhay
Nuclear Factor-kappa B (NF-κB) is a transcription factor family that regulates a large number of genes that are involved in important physiological processes, including survival, inflammation, and immune responses. More recently, constitutive expression of NF-κB has been associated with several types of cancer. In addition, microorganisms, such as viruses and bacteria, cooperate in the activation of NF-κB in tumors, confirming the multifactorial role of this transcription factor as a cancer driver. Recent reports have shown that the NF-κB signaling pathway should receive attention for the development of therapies. In addition to the direct effects of NF-κB in cancer cells, it might also impact immune cells that can both promote or prevent tumor development. Currently, with the rise of cancer immunotherapy, the link among immune cells, inflammation, and cancer is a major focus, and NF-κB could be an important regulator for the success of these therapies. This review discusses the contrasting roles of NF-κB as a regulator of pro- and antitumor processes and its potential as a therapeutic target.

21 July 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
Rafael Cardoso Maciel Costa SilvaRafael Cardoso Maciel Costa Silva
Rafael Cardoso Maciel Costa Silva
LTLeonardo H. Travassos
Leonardo H. Travassos
CPClaudia N. Paiva
Claudia N. Paiva
MBMarcelo T. Bozza
Marcelo T. Bozza
Heme oxygenase (HO-1) mediates the enzymatic cleavage of heme, a molecule with proinflammatory and prooxidant properties. HO-1 activity deeply impacts host capacity to tolerate infection through reduction of tissue damage or affecting resistance, the ability of the host to control pathogen loads. In this Review, we will discuss the contribution of HO-1 in different and complex protozoan infections, such as malaria, leishmaniasis, Chagas disease, and toxoplasmosis. The complexity of these infections and the pleiotropic effects of HO-1 constitute an interesting area of study and an opportunity for drug development.

1 April 2013 in Toxicon
Verified
Journal Article
Closed access
Eduardo Gonçalves Paterson FoxEduardo Gonçalves Paterson Fox
Eduardo Gonçalves Paterson Fox
DSDaniel Russ Solis
Daniel Russ Solis
Lucilene Delazari dos SantosLucilene Delazari dos Santos
Lucilene Delazari dos Santos
JPJose Roberto Aparecido dos Santos Pinto
Jose Roberto Aparecido dos Santos Pinto
AMAnally Ribeiro da Silva Menegasso
Anally Ribeiro da Silva Menegasso
EMEdnildo de Alcântara Machado
Ednildo de Alcântara Machado

4 November 2022 in Cancer Pathogenesis and Therapy
Verified
Journal Article
Open access
Rafael Cardoso Maciel Costa SilvaRafael Cardoso Maciel Costa Silva
Rafael Cardoso Maciel Costa Silva
MLMarcela Freitas Lopes
Marcela Freitas Lopes
LTLeonardo Holanda Travassos
Leonardo Holanda Travassos
The adaptive arm of the immune system is crucial for appropriate antitumor immune responses. It is generally accepted that clusters of differentiation 4+ (CD4+) T cells, which mediate T helper (Th) 1 immunity (type 1 immunity), are the primary Th cell subtype associated with tumor elimination. In this review, we discuss evidence showing that antitumor immunity and better prognosis can be associated with distinct Th cell subtypes in experimental mouse models and humans, with a focus on Th2 cells. The aim of this review is to provide an overview and understanding of the mechanisms associated with different tumor outcomes in the face of immune responses by focusing on the (1) site of tumor development, (2) tumor properties (i. e., tumor metabolism and cytokine receptor expression), and (3) type of immune response that the tumor initially escaped. Therefore, we discuss how low-tolerance organs, such as lungs and brains, might benefit from a less tissue-destructive immune response mediated by Th2 cells. In addition, Th2 cells antitumor effects can be independent of CD8+ T cells, which would circumvent some of the immune escape mechanisms that tumor cells possess, like low expression of major histocompatibility-I (MHC-I). Finally, this review aims to stimulate further studies on the role of Th2 cells in antitumor immunity and briefly discusses emerging treatment options.

3 November 2023 in Cytokine
Verified
Journal Article
Closed access
Rafael Cardoso Maciel Costa SilvaRafael Cardoso Maciel Costa Silva
Rafael Cardoso Maciel Costa Silva
LTLeonardo Holanda Travassos
Leonardo Holanda Travassos
FDFabianno Ferreira Dutra
Fabianno Ferreira Dutra

28 January 2024 in Journal of Molecular Evolution
Verified
Journal Article
Closed access
PDF file
Rafael Cardoso Maciel Costa SilvaRafael Cardoso Maciel Costa Silva
Rafael Cardoso Maciel Costa Silva
FGFábio Mendonça Gomes
Fábio Mendonça Gomes